Cymat Technologies Ltd.
CYMHF
$0.12
$0.000.00%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -80.20% | 233.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -80.20% | 233.74% | |||
| Cost of Revenue | -43.25% | 64.57% | |||
| Gross Profit | -172.39% | 313.28% | |||
| SG&A Expenses | 30.12% | -4.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.87% | 25.47% | |||
| Operating Income | -234.98% | 61.45% | |||
| Income Before Tax | -100.07% | 36.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -100.07% | 36.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -100.07% | 36.89% | |||
| EBIT | -234.98% | 61.45% | |||
| EBITDA | -401.46% | 71.28% | |||
| EPS Basic | -95.52% | 36.79% | |||
| Normalized Basic EPS | -104.76% | 36.36% | |||
| EPS Diluted | -95.52% | 36.79% | |||
| Normalized Diluted EPS | -104.76% | 36.36% | |||
| Average Basic Shares Outstanding | 2.22% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.22% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||